We are inviting adults aged 18-75 living with generalized Myasthenia Gravis (gMG) who are on stable standard-of-care treatment to participate in a Phase III clinical trial evaluating remibrutinib, an oral medication. RELIEVE is a clinical trial is testing the effectiveness and safety of remibrutinib for adults...
[vc_row css_animation="" row_type="row" use_row_as_full_screen_section="no" type="full_width" angled_section="no" text_align="left" background_image_as_pattern="without_pattern"][vc_column][vc_column_text css=""] The ASSESS study combines a longitudinal natural history study and biomarker collection for ALS. It aims to make ALS research accessible to everyone, including those who cannot visit academic medical centers, through new technology that allows remote...
This protocol includes studies on how aging affects the control and coordination of speech production. Various hypotheses are being investigated in our laboratory with the common aim of improving our understanding of the processes and mechanisms underlying normal and disordered speech. The common procedure across these...
[box class="summary"][/box]This protocol includes studies of the control and coordination of speech production. Various hypotheses are being investigated in our laboratory with the common aim of improving our understanding of the processes and mechanisms underlying normal and disordered speech. The common procedure across these studies consists...
